Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. [electronic resource]
Producer: 20070807Description: 143-50 p. digitalISSN:- 1175-3277
- Acute Disease
- Administration, Oral
- Aged
- Angina, Unstable -- therapy
- Angioplasty, Balloon, Coronary -- adverse effects
- Creatine Kinase, MB Form -- blood
- Echocardiography
- Female
- Heart Ventricles -- physiopathology
- Humans
- Hypokinesia
- Male
- Middle Aged
- Myocardial Infarction -- therapy
- Myocardial Reperfusion Injury -- etiology
- Myocardial Revascularization
- Premedication
- Syndrome
- Trimetazidine -- pharmacology
- Troponin I -- blood
- Vasodilator Agents -- pharmacology
- Ventricular Dysfunction, Left -- drug therapy
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.